Histological characteristics of patients.

<p>(A) Steatosis grade according to liver disease etiology and normal/abnormal γ-GT values; (B) Grade of liver inflammation, according to liver disease etiology (Kleiner score for NAFLD, Scheuer score for CHC and CHB) and normal/abnormal γ-GT values; (C) Stage of liver fibrosis, according to liver disease etiology (Kleiner score for NAFLD, Scheuer score for CHC and CHB) and normal/abnormal γ-GT values.</p

Demographic, Clinical, Biochemical, and Histological Features of 843 Patients with Metabolic and Viral Chronic Liver Diseases, According to the Etiology and to γ-glutamiltranspherase Serum Levels.

<p>Data are given as mean ± SD or as number of cases. Yrs, indicates years; HOMA, homeostasis model assessment. * Kleiner score for non-alcoholic fatty liver disease patients, and Scheuer score for genotype 1 chronic hepatitis C, and chronic hepatitis B patients.</p

Univariate and Multivariate Analysis of Risk Factors Associated with Severe Fibrosis (F3–F4) in 843 Patients with Metabolic and Viral Chronic Liver Diseases by Logistic Regression Analysis.

<p>Data are given as mean±SD or as number of cases. Yrs, indicates years; γ-GT, γ-glutamiltranspherase.</p

Univariate and Multivariate Analysis of Risk Factors Associated with Severe Fibrosis (F3–F4) in 504 Patients with Metabolic and Viral Chronic Liver Disease and normal GGT values, by Logistic Regression Analysis.

<p>Data are given as mean ± SD or as number of cases. Yrs, indicates years; γ-GT, γ-glutamiltranspherase.</p

Diagnostic performance of GGT in predicting severe liver fibrosis.

<p>HOMA, homeostasis model assessment; γ-GT, γ-glutamiltranspherase; PPV, positive predictive value; NPV, negative predictive value. * p value of corresponding AUC compared to γ-GT AUC (pairwise comparison).</p

Relationship between NT-pro-BNP levels and clinical and echocardiographic data on linear regression analysis in cirrhotic patients.

<p>Relationship between NT-pro-BNP levels and clinical and echocardiographic data on linear regression analysis in cirrhotic patients.</p

Demographic, clinical, laboratory and echocardiographic features of cirrhotic patients according to presence or absence of ascites.

<p>Demographic, clinical, laboratory and echocardiographic features of cirrhotic patients according to presence or absence of ascites.</p

NT pro BNP serum levels and echocardiographic features of 58 cirrhotic patients and 28 matched controls.

<p>NT pro BNP serum levels and echocardiographic features of 58 cirrhotic patients and 28 matched controls.</p

Demographic, clinical, laboratory and echocardiographic features of cirrhotic patients according to presence or absence of F2-F3 oesophageal varices.

<p>Demographic, clinical, laboratory and echocardiographic features of cirrhotic patients according to presence or absence of F2-F3 oesophageal varices.</p

Cirrhotic patients with and without ascites compared to control hypertensive population had significantly higher NT pro-BNP plasma levels.

<p>Cirrhotic patients with and without ascites compared to control hypertensive population had significantly higher NT pro-BNP plasma levels.</p